Is Palantir Stock Going to Crash?
AI and data analytics major Palantir (NASDAQ:PLTR) has become something…
Sell
20
ARDT Quote, Financials, Valuation and Earnings
Last price:
$8.55
Seasonality move
:
-18.51%
Day range:
$8.40 - $8.61
52-week range:
$8.22 - $15.65
Dividend yield:
0%
P/E ratio:
5.93x
P/S ratio:
0.19x
P/B ratio:
0.99x
Volume:
368K
Avg. volume:
450.5K
1-year change:
-43.87%
Market cap:
$1.2B
Revenue:
$6B
EPS (TTM):
$1.44
Analysts' Opinion
-
Consensus RatingArdent Health, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 7 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $13.07, Ardent Health, Inc. has an estimated upside of 52.65% from its current price of $8.56.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $8.80 representing -2.8% downside risk from its current price of $8.56.
Fair Value
-
According to the consensus of 11 analysts, Ardent Health, Inc. has 52.65% upside to fair value with a price target of $13.07 per share.
ARDT vs. S&P 500
-
Over the past 5 trading days, Ardent Health, Inc. has underperformed the S&P 500 by -3.48% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Ardent Health, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Ardent Health, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Ardent Health, Inc. reported revenues of $1.6B.
Earnings Growth
-
Ardent Health, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Ardent Health, Inc. reported earnings per share of -$0.17.
Enterprise value:
3.3B
EV / Invested capital:
--
Price / LTM sales:
0.19x
EV / EBIT:
8.64x
EV / Revenue:
0.52x
PEG ratio (5yr expected):
0.05x
EV / Free cash flow:
21.21x
Price / Operating cash flow:
7.82x
Enterprise value / EBITDA:
6.17x
Gross Profit (TTM):
$6.2B
Return On Assets:
5.88%
Net Income Margin (TTM):
4.69%
Return On Equity:
19.14%
Return On Invested Capital:
7.77%
Operating Margin:
1.34%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $5.2B | $5.7B | $6.3B | $1.4B | $1.6B | |
| Gross Profit | $4.1B | $5.6B | $2.3B | $1.4B | $215.2M | |
| Operating Income | $254.9M | $290.4M | $380.1M | $74.7M | $16.5M | |
| EBITDA | $393.1M | $434.8M | $532.6M | $111.4M | $55.6M | |
| Diluted EPS | $0.41 | $0.64 | $1.44 | $0.18 | -$0.17 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | $1.7B | $2B | |
| Total Assets | -- | -- | -- | $4.8B | $5.2B | |
| Current Liabilities | -- | -- | -- | $887.3M | $943.2M | |
| Total Liabilities | -- | -- | -- | $3.4B | $3.5B | |
| Total Equity | -- | -- | -- | $1.4B | $1.6B | |
| Total Debt | -- | -- | -- | $2.3B | $2.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | $263M | $364.1M | $92.2M | $151.8M | |
| Cash From Investing | -- | -$171.7M | -$233.4M | -$44.5M | -$58.6M | |
| Cash From Financing | -- | $27.2M | -$84.3M | $181M | -$24.4M | |
| Free Cash Flow | -- | $99.3M | $154.9M | $48.7M | $93M | |
ARDT
Sector
Market Cap
$1.2B
$25.9M
Price % of 52-Week High
54.7%
51.6%
Dividend Yield
0%
0%
Shareholder Yield
-0.24%
-1.66%
1-Year Price Total Return
-43.87%
-18.99%
Beta (5-Year)
--
0.485
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$8.63
200-day SMA
Sell
Level
$12.25
Bollinger Bands (100)
Sell
Level
8.98 - 14.12
Chaikin Money Flow
Sell
Level
-1.2M
20-day SMA
Sell
Level
$8.86
Relative Strength Index (RSI14)
Sell
Level
41.97
ADX Line
Sell
Level
32.74
Williams %R
Neutral
Level
-70.6897
50-day SMA
Sell
Level
$9.25
MACD (12, 26)
Sell
Level
-0.25
25-day Aroon Oscillator
Sell
Level
-32
On Balance Volume
Neutral
Level
5.8M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.0584)
Sell
CA Score
(Annual)
Level (-1.1577)
Buy
Beneish M-Score
(Annual)
Level (-2.5911)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (0.3966)
Buy
Piotroski F Score
(Annual)
Level (9)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Ardent Health, Inc. engages in the provision of healthcare and related services. It also owns and operates hospitals through its subsidiaries. The company was founded in 1993 and is headquartered in Brentwood, TN.
Stock Forecast FAQ
In the current month, ARDT has received 7 Buy ratings 4 Hold ratings, and 0 Sell ratings. The ARDT average analyst price target in the past 3 months is $13.07.
-
Where Will Ardent Health, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Ardent Health, Inc. share price will rise to $13.07 per share over the next 12 months.
-
What Do Analysts Say About Ardent Health, Inc.?
Analysts are divided on their view about Ardent Health, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Ardent Health, Inc. is a Sell and believe this share price will drop from its current level to $8.80.
-
What Is Ardent Health, Inc.'s Price Target?
The price target for Ardent Health, Inc. over the next 1-year time period is forecast to be $13.07 according to 11 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is ARDT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Ardent Health, Inc. is a Buy. 7 of 11 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ARDT?
You can purchase shares of Ardent Health, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Ardent Health, Inc. shares.
-
What Is The Ardent Health, Inc. Share Price Today?
Ardent Health, Inc. was last trading at $8.55 per share. This represents the most recent stock quote for Ardent Health, Inc.. Yesterday, Ardent Health, Inc. closed at $8.56 per share.
-
How To Buy Ardent Health, Inc. Stock Online?
In order to purchase Ardent Health, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get ARDT Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ARDT
Sector
P/E ratio
5.93x
23.82x
PEG ratio
0.05x
-0.01x
P/B ratio
0.99x
1.83x
Price / LTM sales
0.19x
1.56x
Growth Metrics
ARDT
Sector
Revenue growth
8.76%
4.18%
Earnings growth
-190.13%
9.66%
Revenue (5-year growth)
14.72%
6.28%
Earnings forecast
$0.22
-$0.18
Profitability
ARDT
Sector
Profitability FY 2024
$5.8B
$3.1M
Return on invested capital
7.77%
-32.89%
Return on assets
5.88%
-29.56%
Return on equity
19.14%
-38.66%
Earnings Date
Last Earnings Date
Nov
12
Next Earnings Date
Mar
4
Estimated Next Earnings Date
Feb
11
Balance Sheet
ARDT
Sector
Total cash
$609.4M
$25.2M
Short term investments
--
$25.1M
Total assets
$5.3B
$73M
Long term debt
$2.3B
$3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did AMD Stock Go Up?
Since January 9th, shares of chipmaker AMD (NASDAQ:AMD) have been…
Will Data Centers Be In Space?
With demand for data centers seemingly growing by the day,…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
47
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
56
INTC alert for Jan 24
Intel Corp. [INTC] is down 17.01% over the past day.
Buy
64
BNR alert for Jan 24
Burning Rock Biotech Ltd. [BNR] is down 12.81% over the past day.
Sell
19
APGE alert for Jan 24
Apogee Therapeutics, Inc. [APGE] is down 12.28% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
